Allogeneic Hematopoietic Stem Cell Transplantation in Patients with Multiple Myeloma

被引：0
|
作者：
Firsova, Maya [1 ]
Mendeleeva, Larisa [1 ]
Solovev, Maxim [1 ]
Kuzmina, Larisa [1 ]
Julhakyan, Hunan [1 ]
Savchenko, Valeriy [1 ]
机构：
[1] Natl Res Ctr Hematol, Moscow, Russia
来源：
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA | 2020年 / 20卷
关键词：
multiple myeloma; allogeneic hematopoietic stem cell transplant; allo-HSCT; high-risk; progression; acute GVHD; transplant-related mortality; MM;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
MM-269
引用
下载
收藏
页码：S305 / S306
页数：2
相关论文
共 50 条
  • [21] Hematopoietic Stem Cell Transplantation in Multiple Myeloma
    Harousseau, Jean-Luc
    JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK, 2009, 7 (09): : 961 - 970
  • [22] The efficacy and tolerability of pomalidomide treatment for multiple myeloma in patients after allogeneic hematopoietic stem cell transplantation
    Janjetovic, S.
    Ayuk, F.
    Christopeit, M.
    Wolschke, C.
    von Pein, U. -M.
    Stuebig, T.
    Kroeger, N.
    BONE MARROW TRANSPLANTATION, 2015, 50 : S300 - S301
  • [23] Efficacy of Allogeneic Hematopoietic Stem Cell Transplantation in Young and High-Risk Multiple Myeloma Patients
    Pan, Pan
    Jiang, Erlie
    Pang, Aiming
    BLOOD, 2023, 142
  • [24] Predictors of prolonged survival after allogeneic hematopoietic stem cell transplantation for multiple myeloma
    Bashir, Qaiser
    Khan, Hassan
    Orlowski, Robert Z.
    Amjad, Ali Imran
    Shah, Nina
    Parmar, Simrit
    Wei, Wei
    Rondon, Gabriela
    Weber, Donna M.
    Wang, Michael
    Thomas, Sheeba K.
    Shah, Jatin J.
    Qureshi, Sofia R.
    Dinh, Yvonne T.
    Popat, Uday
    Anderlini, Paolo
    Hosing, Chitra
    Giralt, Sergio
    Champlin, Richard E.
    Qazilbash, Muzaffar H.
    AMERICAN JOURNAL OF HEMATOLOGY, 2012, 87 (03) : 272 - 276
  • [25] Outcome of reduced-intensity allogeneic hematopoietic stem cell transplantation for multiple myeloma
    Kikuchi, Taku
    Mori, Takehiko
    Koda, Yuya
    Kohashi, Sumiko
    Kato, Jun
    Toyama, Takaaki
    Nakazato, Tomonori
    Aisa, Yoshinobu
    Shimizu, Takayuki
    Okamoto, Shinichiro
    INTERNATIONAL JOURNAL OF HEMATOLOGY, 2015, 102 (06) : 670 - 677
  • [26] Outcome of reduced-intensity allogeneic hematopoietic stem cell transplantation for multiple myeloma
    Taku Kikuchi
    Takehiko Mori
    Yuya Koda
    Sumiko Kohashi
    Jun Kato
    Takaaki Toyama
    Tomonori Nakazato
    Yoshinobu Aisa
    Takayuki Shimizu
    Shinichiro Okamoto
    International Journal of Hematology, 2015, 102 : 670 - 677
  • [27] Reduced-Intensity Allogeneic Hematopoietic Stem Cell Transplantation for Relapsed Multiple Myeloma
    Efebera, Yvonne A.
    Qureshi, Sofia R.
    Cole, Suzanne M.
    Saliba, Rima
    Pelosini, Matteo
    Patel, Ronak M.
    Koca, Ebru
    Mendoza, Floralyn L.
    Wang, Michael
    Shah, Jatin
    Alousi, Amin
    Hosing, Chitra
    Popat, Uday
    Kebriaei, Partow
    Anderlini, Paolo
    Khouri, Issa F.
    Champlin, Richard
    Giralt, Sergio
    Qazilbash, Muzaffar H.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2010, 16 (08) : 1122 - 1129
  • [28] Different indications for allogeneic Hematopoietic Stem cell transplantation in Multiple Myeloma over the years
    Donnini, I.
    Nozzoli, C.
    Gozzini, A.
    Staderini, M.
    Guarrera, A.
    Guidi, S.
    Saccardi, R.
    Bosi, A.
    BONE MARROW TRANSPLANTATION, 2016, 51 : S308 - S308
  • [29] Role of allogeneic stem cell transplantation in multiple myeloma
    Kumar S.
    Current Hematologic Malignancy Reports, 2008, 3 (2) : 99 - 106
  • [30] Allogeneic stem cell transplantation for multiple myeloma: is there a future?
    Dhakal, B.
    Vesole, D. H.
    Hari, P. N.
    BONE MARROW TRANSPLANTATION, 2016, 51 (04) : 492 - 500
12345